504 related articles for article (PubMed ID: 23434448)
21. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
[TBL] [Abstract][Full Text] [Related]
22. Intrathoracic chemo-thermotherapy with radiofrequency waves after extrapleural pneumonectomy for malignant pleural mesothelioma.
Tokunaga T; Higashiyama M; Okami J; Maeda J; Fujiwara A; Kodama K
Interact Cardiovasc Thorac Surg; 2011 Sep; 13(3):267-70. PubMed ID: 21680551
[TBL] [Abstract][Full Text] [Related]
23. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
Cao KJ; Cui NJ
Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
[TBL] [Abstract][Full Text] [Related]
24. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
[TBL] [Abstract][Full Text] [Related]
25. Clinical indications and results after chest wall resection for recurrent mesothelioma.
Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
[TBL] [Abstract][Full Text] [Related]
26. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
[TBL] [Abstract][Full Text] [Related]
27. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
[TBL] [Abstract][Full Text] [Related]
28. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
[TBL] [Abstract][Full Text] [Related]
30. Trimodality therapy for malignant pleural mesothelioma.
Buduhan G; Menon S; Aye R; Louie B; Mehta V; Vallières E
Ann Thorac Surg; 2009 Sep; 88(3):870-5; discussion 876. PubMed ID: 19699914
[TBL] [Abstract][Full Text] [Related]
31. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
de Perrot M; Uy K; Anraku M; Tsao MS; Darling G; Waddell TK; Pierre AF; Bezjak A; Keshavjee S; Johnston MR
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):111-6. PubMed ID: 17198794
[TBL] [Abstract][Full Text] [Related]
32. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
[TBL] [Abstract][Full Text] [Related]
33. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
[TBL] [Abstract][Full Text] [Related]
34. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
35. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermic pleural perfusion with cisplatin: early clinical experience.
Yellin A; Simansky DA; Paley M; Refaely Y
Cancer; 2001 Oct; 92(8):2197-203. PubMed ID: 11596038
[TBL] [Abstract][Full Text] [Related]
37. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
38. Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.
Migliore M; Calvo D; Criscione A; Viola C; Privitera G; Spatola C; Parra HS; Palmucci S; Ciancio N; Caltabiano R; Di Maria G
Future Oncol; 2015; 11(2 Suppl):47-52. PubMed ID: 25662329
[TBL] [Abstract][Full Text] [Related]
39. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
Stewart DJ; Martin-Ucar A; Pilling JE; Edwards JG; O'Byrne KJ; Waller DA
Ann Thorac Surg; 2004 Jul; 78(1):245-52. PubMed ID: 15223437
[TBL] [Abstract][Full Text] [Related]
40. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
